TRIM21 and interstitial lung disease: Recently, Shao et al. investigated 150 patients with anti-Ro52 antibodies without anti-Ro60 antibody positivity in their ILD cohort and found that 138 were positive for either anti-synthetase (n = 88; 61.5%) or anti-MDA5 (n = 42; 38.5%) [46].